ifenprodil has been researched along with Arterial Occlusive Diseases in 5 studies
ifenprodil: NMDA receptor antagonist
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branchereau, A | 1 |
| Rouffy, J | 1 |
| O'Mahony, S | 1 |
| Noonan, D | 1 |
| Harkány, T | 1 |
| De Jong, GI | 1 |
| Nyakas, C | 1 |
| Leonard, BE | 1 |
| Marquis, P | 1 |
| Lecasble, M | 1 |
| Passa, P | 1 |
| Natali, J | 1 |
| Kieny, R | 1 |
| Le Bas, P | 1 |
| Benhamou, M | 1 |
| Molkhou, JM | 1 |
| Costes, Y | 1 |
| Pruniaux, T | 1 |
| Roullier, M | 1 |
| Bourgeois, F | 1 |
| Flicoteaux, H | 1 |
| Neidhardt, A | 1 |
| Barale, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Study Between Systemic Analgesia and Continuous Sciatic Nerve Block in Patients With Chronic Obstructive Arterial Disease and Ischemic Pain in Lower Limbs[NCT02841488] | Phase 3 | 56 participants (Anticipated) | Interventional | 2016-09-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for ifenprodil and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Double-Blind Method; Female; Humans; Leg; Male; | 1995 |
[Quality of life of patient with peripheral arterial obliterative disease treated with ifenprodil tartrate. Results of an ARTEMIS study].
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Male; Piperidines; Prospective Studies; Quality o | 1998 |
[Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
Topics: Arterial Occlusive Diseases; Double-Blind Method; Female; Humans; Leg; Male; Middle Aged; Multicente | 1989 |
2 other studies available for ifenprodil and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Ifenprodil attenuates the loss of parietal cortical parvalbumin immunoreactivity after focal cerebral ischemia in the mouse.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Arteries; Excitatory Amino Acid Antagonists; Immunohi | 1997 |
[Action of ifenprodil tartrate in obliterative arteriopathies of the lower limbs. Combined studies using proximal blood flow and distal transcutaneous oxygen pressure].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Gas Monitoring, Transcutaneous; Female; Humans; Leg; | 1986 |